An advanced metabolic blend combining Retatrutide (triple receptor agonist) and Tirzepatide (dual GIP/GLP-1 agonist) for comprehensive weight management and metabolic optimization. This powerful combination leverages Retatrutide's triple activation of GLP-1, GIP, and glucagon receptors alongside Tirzepatide's dual GIP/GLP-1 action, creating a synergistic effect that targets multiple metabolic pathways simultaneously.